Aristotle University Of Thessaloniki (AUTH)
Επίδραση των φαρμάκων για την πνευμονική υπέρταση στην έκφραση των γλυκοζαμινογλυκανών και μεταλλοπρωτεασών σε προωτογενείς καλλιέργειες λείων μυϊκών κυττάρων πνευμονικής αρτηρίας ανθρώπων
Abstract
dc:descriptionThis thesis concerns the investigation of the pathophysiology of idiopathic pulmonary hypertension (IPAH), a rare disease with very severe morbidity and a high mortality rate. During the last 20 years great progress has been achieved in understanding the pathophysiology of the disease, which includes the improvement of both the early diagnosis of patients and pharmacotherapy. The prevalent specific medication is based upon enhancing prostacyclin’s and nitrogen oxide’s action (e.g. sildenafil) as well as the inhibition of endothelin-1 (e.g. bosentani). One of the fields that remain to be explained is the contribution of the extracellular matrix molecules in tissue remodeling observed in IAPH, given that extracellular matrix (ECM) molecules such as glycosaminoglycans (GAG), proteoglycans (PG) and the connective tissue metalloproteases (MMP) involved in tissue remodeling and have been reported to be associated with other lung diseases that exhibit tissue remodeling. In the present study we investigated the role of GAG, PG and MMP in IPAH. The study was performed on homogenized lung tissue and on primary cultures of pulmonary artery smooth muscle cells (PASMC) obtained from 12 patients with IPAH and 10 healthy organ donors. The PASMCs were also investigated for the effect of drugs sildenafil and bosentani in the expression of GAG, PG and MMP, as well as the effect of the transforming growth factor-b1 (TGF-b1) and the bone morphogenetic protein-2 (BMP-2). These two growth factors are key regulators of the synthesis of ECM molecules and they are directly involved in the pathophysiology of IPAH. This system is the closest simulation of an experimental model in tissue remodeling associated with IPAH. It was discovered that the samples of lung tissue and the PASMCs express the following GAGs: HA, heparan sulfate, dermatan sulfate and chondroitin sulfate. A statistically significant increase of HA and reduction of heparan sulfate, dermatan sulfate and chondroitin sulfate was observed in the lungs of patients with IPAH. Also, the molecular mass of HA in the healthy lung tissue was found over 1000 kDa, whereas HA from patients with IPAH was estimated at approximately 200 kDa. These differences in HA levels are owed to the modulation of expression of the enzymes that metabolize it. The samples of lung tissue and PASMCs express the enzymes that synthesize HA: Has1, Has2 and Has3 and the enzymes that degrade HA: Hyal1, Hyal2, Hyal3 and Hyal4, as well as the HA receptors: CD44 and Rhamm. The expression and protein levels of HAS1 are statistically significantly increased, whereas the expression of HYAL1 is reduced in patients with IPAH. The results support the theory that high molecular weight HA is associated with physiological processes, while the low molecular weight HA is associated with inflammatory conditions. In the experimental model simulation of tissue remodeling associated with IPAH, it was found that the addition of both TGF-b1, and BMP-2 in healthy PASMCs, causes dose-dependent and time-dependent modulation of the expression of GAGs, HA and HAS-1, similar to that observed in patients with IPAH. The intracellular signaling of TGF-b1 in the de novo synthesis, secretion and deposition of GAGs from PASMCs was discovered to be mediated via the SMAD and p38 MAPK signaling pathways. Regarding the proteoglycans, both the healthy and patient samples of lung tissue, as well as the PASMCs, were found to express versican, biglycan, decorin, syndecan and perlekani. Apart from that, a statistically significant reduction in the expression of versican V1 and decorin was discovered in the patients with IPAH. It was also found that TGF-b1 induces in a dose-dependent and time-dependent manner the expression of versican V0 and V1, biglycan, syndecan and perlekanis and reduces the expression of decorin. Similarly, the BMP-2 induces a time-dependent induction in the expression of versican V0, versican V1, perlekanis and syndecan. The induction of expression of specific proteoglycans caused by TGF-b1 and BMP-2 may be related to the reconstruction of lung tissue observed in IPAH. Regarding the influence of drugs sildenafil and bosentani they were found to not significantly affect the levels HA, the expression of Has, Hyal, CD44 and RHAMM and the activity levels and MMP and TIMP in PASMCs. However, these drugs, either alone or combined reduce the TGF-b1 or BMP-2 induced gene expression of proteoglycans versican V0, versican V1, biglycan, syndecan and perlekanis in PASMCs, but the reduction is not statistically significant. The results of the present study indicate that the extracellular matrix molecules such as glycosaminoglycans, particularly hyaluronic acid, proteoglycans, and gelatinases are involved in the pathophysiology of IPAH and could be potential pharmacological targets for the treatment of this incurable and fatal disease. The effect of drugs sildenafil and bosentani, administered in IPAH, indicates potential beneficial effects due to the induced return to normal levels of gene expression of proteoglycans, but the statistical significance remains to be proved on a larger number of patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Χολέβας, Χρήστος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29113